Inventor
Susan Mary Daluge
Inventor
Chapel Hill, NC, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07HSugars5%
Y02ATechnologies for adaptation to climate change2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
7,115,590'Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents'20067,002,012'Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders'20066,870,053'Chloropyrimidine intermediates'20056,770,267'Methods of treating periodontal disease'20046,630,477'Therapeutic nucleoside compound'20036,608,069'Phenyl xanthine derivatives'20036,555,687'Chloropyrimidine intermediates'20036,552,193'Chloropyrimidine intermediates'20036,455,507'Benzimidazole derivatives'20026,448,403'Chloropyrimidine intermediates'20026,437,124'Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl) phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders'20026,392,085'Therapeutic nucleosides'20026,355,646'Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders'20026,087,501'Chloropyrimidine intermediates and processes for their preparation'20006,077,832'Antiviral benzimidazole nucleoside analogues and a method for their preparation'20005,998,605'Antiviral benzimidazole nucleoside analogues and method for their preparation'19995,998,398'2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity'19995,919,941'Intermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acid'19995,917,041'Chloropyrimidine intermediates'19995,917,042'Process for the preparation of 2,5-diamino-4,6-dichloropyrimidine'19995,912,356'Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring'19995,840,990'Intermediates to carbocyclic nucleosides'19985,808,147'Therapeutic nucleosides'19985,776,940'Phenylxanthine derivatives'19985,641,889'Therapeutic nucleosides'19975,637,574'Therapeutic nucleosides'19975,574,149'Method of treating HIV infections with 2\',3\'-dideoxy-3\'-fluoro-5-chlorouridine'19965,534,535'Therapeutic nucleosides'19965,420,115'Method for the treatment of protoza infections with 2.sup.1 -deoxy-2.sup.1 -fluoropurine nucleosides'19955,399,580'Therapeutic nucleosides-uses'19955,206,435'4-amino-2-cyclopentene-1-methanol'19935,089,500'Therapeutic nucleosides'19925,087,697'Therapeutic nucleosides'19925,070,078'Antiviral compounds'19915,049,671'6-substituted purine carbocyclic nucleosides'19915,039,689'Antiparasitic 3(4-amino benzotriazo-1-yl-)1,2-cyclopentanediols'19915,034,394'Therapeutic nucleosides'19915,017,577'Methods for treating viral infection'19915,015,647'Method for treating viral infections'19914,981,857'Purine Derivatives'19914,879,296'Xanthine derivatives'19894,761,475'2,4-diaminopyrimidines substituted with heterobicyclomethyl radicals at the 5 position useful as antibacterials'19884,603,136'Monoheteroring compounds and their use'19864,590,271'2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials'19864,587,342'2,4-diamino-(substituted-benzopyran(quinolyl,isoquinoly)methyl)pyrimidine s useful as antibacterials'19864,438,267'Monoheteroring compounds and their use'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–1988Patents assigned to DALUGE SUSAN M (4)· patent assignee history
1984–1988Patents assigned to SKONEZNY PAUL M (4)· patent assignee history
1984–2006Based in Chapel Hill, NC, US· patent location history
1986–1996Patents assigned to BURROUGHS WELLCOME CO (15)· patent assignee history
1996–2002Patents assigned to GLAXO WELLCOME INC (15)· patent assignee history
2002–2006Patents assigned to SMITHKLINE BEECHAM CORP (10)· patent assignee history
2002–2003Based in Research Triangle Park, NC, US· patent location history
2003–2006Based in Durham, NC, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BURROUGHS WELLCOME CO | 15 | 1986–1996 |
| GLAXO WELLCOME INC | 15 | 1996–2002 |
| SMITHKLINE BEECHAM CORP | 10 | 2002–2006 |
| DALUGE SUSAN Mself | 4 | 1984–1988 |
| SKONEZNY PAUL M | 4 | 1984–1988 |
Locations
| Location | Patents | Span |
|---|---|---|
| Chapel Hill, NC, US | 42 | 1984–2006 |
| Durham, NC, US | 2 | 2003–2006 |
| Research Triangle Park, NC, US | 2 | 2002–2003 |